Department of Paediatrics

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials.

Ndung'u T. et al, (2026), Lancet HIV, 13, e271 - e281

Deleterious coding variation associated with autism is shared across ancestries.

Natividad Avila M. et al, (2026), Nat Med

Corrigendum to "Learnings from a registry-based cohort study for spinal muscular atrophy disease" [Neuromuscular Disorders, Volume 59, February 2026, 106332].

Jonker CJ. et al, (2026), Neuromuscul Disord

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Gagnon LL. et al, (2026), Leukemia

Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules

Kelly E., (2026)

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines (Basel), 14

Exploring the ethics of tuberculosis human challenge models.

Rohrig A. et al, (2026), J Med Ethics, 52, 251 - 260

Human-specific features of the cerebellum and ZP2-regulated synapse development.

Kim S-K. et al, (2026), Cell, 189, 1802 - 1819.e28

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Genome-scale functional mapping of the mammalian whole brain with in vivo Perturb-seq.

Shi T. et al, (2026)

Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.

Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37

Predicting how perturbations reshape cellular trajectories with PerturbGen

Chi Hao Ly K. et al, (2026)

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Judson MC. et al, (2026), J Neurodev Disord, 18

Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.

Hausdorff WP. et al, (2026), Vaccine, 75

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders.

Shen Y. et al, (2026), Cell Stem Cell, 33, 421 - 437.e7

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.

González-Martínez I. et al, (2026), Am J Hum Genet, 113, 529 - 547

Search results

Showing results for